echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > Frequent policies, transformation and upgrading of traditional Chinese Medicine

    Frequent policies, transformation and upgrading of traditional Chinese Medicine

    • Last Update: 2018-12-10
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    [China Pharmaceutical network industry trends] the quality of traditional Chinese medicine is the basis of the healthy development strategy of traditional Chinese medicine industry However, problems such as pesticide residues, heavy metals, mold pollution and increasing number of fake and inferior products of traditional Chinese medicine cause frequent safety incidents of traditional Chinese medicine The industry believes that in this context, if China wants to do a good job in traditional Chinese medicine, it is necessary to establish a pharmaceutical standard system with Pharmacopoeia as the core The author understands that in recent years, especially since 2017, China's policies on traditional Chinese medicine have been frequent, and the transformation and upgrading of traditional Chinese medicine are under way (frequent policies, transformation and upgrading of traditional Chinese medicine are under way photo source: China Pharmaceutical network) safety of traditional Chinese medicine directly affects the clinical efficacy of traditional Chinese medicine, directly related to the safety and effectiveness of people's medication In order to ensure the development of traditional Chinese medicine industry, the safety of traditional Chinese medicine has been attached great importance in China In January 2018, China issued the outline for the preparation of Chinese Pharmacopoeia, which requires in terms of safety: effectively control the impact of exogenous pollutants on the safety of traditional Chinese medicine, comprehensively formulate the limit standards for heavy metals, harmful elements and pesticide residues in traditional Chinese medicine, decoction pieces, and comprehensively formulate the limit standards for mycotoxins in moldy traditional Chinese medicine and decoction pieces On October 8, 2017, the State Food and drug administration again proposed to launch the re evaluation of traditional Chinese medicine injection, starting from the source again, and comprehensively carry out the safety, effectiveness, stability and controllability evaluation On July 1, 2017, the law of traditional Chinese medicine was officially implemented, which is the first law in the field of traditional Chinese medicine and will promote the development of traditional Chinese medicine products It is clear that it is forbidden to use highly toxic and highly toxic pesticides in the process of traditional Chinese medicine planting In the aspect of production and circulation of traditional Chinese medicine, strengthening the quality supervision and management of the whole process of production and circulation of traditional Chinese medicine is conducive to ensuring the quality and safety of traditional Chinese medicine On August 31, 2018, in order to regulate the production of Chinese herbal pieces, the State Food and Drug Administration issued the notice on the work plan for centralized quality control of Chinese herbal pieces Among them, it is required to strictly investigate and deal with the illegal behaviors in the production process of Chinese herbal pieces; strictly investigate and deal with the illegal behaviors in the circulation and use process of Chinese herbal pieces; strictly investigate and deal with the unqualified Chinese herbal pieces; strictly investigate and deal with the illegal production and operation of Chinese herbal pieces In terms of TCM standardization, the industry said that it is inevitable for TCM to go to the world, and the international standardization of TCM is an important way to internationalize TCM On December 6, 2018, the State Pharmacopoeia Commission issued the announcement on the contents to be revised of the red ginseng standard, Volume I, 2015 edition of Chinese Pharmacopoeia On November 30, 2018, the international standard of traditional Chinese Medicine - Panax notoginseng was released and implemented in Kunming This is the first international standard formulated by China for the quality evaluation of medicinal products, which fills the gap in the field of international standard formulation and revision in China It is reported that compared with the current pharmacopoeia standard of China, the main feature of the standard is to classify the Panax notoginseng according to the market rules, and reasonably stipulate some pesticide and heavy metal control indicators according to the requirements of the international market In October 2018, the basic requirements for standardized Decoction center developed by China was approved and implemented globally It is reported that this is the first world standard passed in the field of traditional Chinese medicine decoction in the world It will also become an effective means for traditional Chinese medicine enterprises to overcome international technical barriers and promote the international competitiveness of traditional Chinese medicine products, so as to make the development of traditional Chinese medicine more standardized On September 21, 2018, the publication of the proposed revised standard of Ginkgo biloba extract in the 2015 edition of Chinese Pharmacopoeia was published On September 18, 2018, the publication and release of Yaobitong capsule, the first part of 2015 edition of Chinese Pharmacopoeia, is to be revised On March 29, 2018, the National Pharmacopoeia Committee issued the announcement on the revision of "Banlangen Granules" standard to enhance the attention, attention and participation of pharmaceutical manufacturers in the proposed revision of the quality standard It is reported that since the implementation of 2015 edition of Chinese Pharmacopoeia, the quality standards of traditional Chinese medicine products need to be improved However, for some products, the road of standard revision is still far away.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.